Trypsin

DB11237ApprovedInvestigationalVet approvedProtein Based Therapies

Trypsin is a naturally occurring proteolytic enzyme found in the digestive tract of mammals. Used clinically in combination with bromelain and rutosides in the treatment of some inflammatory conditions. Trypsin is a serine protease that plays an essential role in protein hydrolysis and absorption in mammals.

Resolves to

Compound
UNIIGV54A213NNCAS9002-07-7
Clinical / RWD
RxNorm10890ATCB06AA07ATCD03BA01ATCM09AB52
Targets
P55085F2RL1

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Drug interactionStructured to mechanism, not free text
Sign in
21Clinical trialsPhase, status and sponsor resolved per trial
Sign in
5Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
5ContraindicationsEach with its own population and attribute set
Sign in
11Marketed productsAcross 3 countries and 7 labellers
Sign in
3ATC codesIncluding every combination product, plus 11 drug categories
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Trypsin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In